Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Myriad Genetics, Inc (NASDAQ: MYGN) closed at $17.99 down -18.08% from its previous closing price of $21.96. In other words, the price has decreased by -$18.08 from its previous closing price. On the day, 3.74 million shares were traded. MYGN stock price reached its highest trading level at $20.06 during the session, while it also had its lowest trading level at $16.86.
Ratios:
For a deeper understanding of Myriad Genetics, Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.96. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.18.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Morgan Stanley on September 19, 2024, initiated with a Equal-Weight rating and assigned the stock a target price of $32.
On August 28, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $35.
On June 27, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $29.Scotiabank initiated its Sector Outperform rating on June 27, 2024, with a $29 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 11 ’24 when DIAZ PAUL J sold 15,000 shares for $22.93 per share. The transaction valued at 343,950 led to the insider holds 962,378 shares of the business.
DIAZ PAUL J bought 15,000 shares of MYGN for $343,950 on Oct 11 ’24. On Aug 21 ’24, another insider, Ancona Margaret, who serves as the Officer of the company, bought 11,538 shares for $27.82 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MYGN now has a Market Capitalization of 1633858944 and an Enterprise Value of 1679858176. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.67 while its Price-to-Book (P/B) ratio in mrq is 2.21. Its current Enterprise Value per Revenue stands at 2.094 whereas that against EBITDA is -34.283.
Stock Price History:
Over the past 52 weeks, MYGN has reached a high of $29.30, while it has fallen to a 52-week low of $15.03. The 50-Day Moving Average of the stock is -29.63%, while the 200-Day Moving Average is calculated to be -24.52%.
Shares Statistics:
For the past three months, MYGN has traded an average of 657.75K shares per day and 787710 over the past ten days. A total of 89.90M shares are outstanding, with a floating share count of 87.40M. Insiders hold about 3.76% of the company’s shares, while institutions hold 102.09% stake in the company. Shares short for MYGN as of 1728950400 were 4494424 with a Short Ratio of 6.83, compared to 1726185600 on 3939214. Therefore, it implies a Short% of Shares Outstanding of 4494424 and a Short% of Float of 6.9299996.
